May break above the trendline after long consolidation.
MACD shows bullishness, could be a good spot for long
push up above the 200MA, with falling revenues, will GSK has its bottom in?
LLY breakout with volume are fake breakdown, good buy spot
a long base building with volume increase lately, ready to break out.
Pfizer break out with high volume, is a buy, good dividend (>3%) also, could go to $40.
LLY may break out of this rising range and go to new high, good to load up shares